Michael Benzaquen

Dr. Michael Benzaquen

Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
MBMichael Benzaquen
Michael Benzaquen
LBLuca Borradori
Luca Borradori
PBPhilippe Berbis
Philippe Berbis
SCSimone Cazzaniga
Simone Cazzaniga
RVRené Valero
René Valero
LFLaurence Feldmeyer
Laurence Feldmeyer

25 August 2019 in Experimental Dermatology
Verified
Journal Article
Open access
PDF file
SSSophie Seite
Sophie Seite
AKAmir Khammari
Amir Khammari
MBMichael Benzaquen
Michael Benzaquen
DMDominique Moyal
Dominique Moyal
BDBrigitte Dréno
Brigitte Dréno
We developed an artificial intelligence algorithm (AIA) for smartphones to determine the severity of facial acne using the GEA scale and to identify different types of acne lesion (comedonal, inflammatory) and postinflammatory hyperpigmentation (PIHP) or residual hyperpigmentation. Overall, 5972 images (face, right and left profiles) obtained with smartphones (IOS and/or Android) from 1072 acne patients were collected. Three trained dermatologists assessed the acne severity for each patient. One acne severity grade per patient (grade given by the majority of the three dermatologists from the two sets of three images) was used to train the algorithm. Acne lesion identification was performed from a subgroup of 348 images using a tagging tool; tagged images served to train the algorithm. The algorithm evolved and was adjusted for sensibility, specificity and correlation using new images. The correlation between the GEA grade and the quantification and qualification of acne lesions both by the AIA and the experts for each image were evaluated for all AIA versions. At final version 6, the GEA grading provided by AIA reached 68% and was similar to that provided by the dermatologists. Between version 4 and version 6, AIA improved precision results multiplied by 1.5 for inflammatory lesions, 2.5 for non‐inflammatory lesions and by 2 for PIHP; recall was improved by 2.6, 1.6 and 2.7. The weighted average of precision and recall or F1 score was 84% for inflammatory lesions, 61% for non‐inflammatory lesions and 72% for PIHP.

29 April 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNicole L. Bertschi
Nicole L. Bertschi
OSOliver Steck
Oliver Steck
FLFabian Luther
Fabian Luther
CBCecilia Bazzini
Cecilia Bazzini
LMLeonhard von Meyenn
Leonhard von Meyenn
CSChristoph Schlapbach
Christoph Schlapbach
T helper 9 (TH9) cells promote allergic tissue inflammation and express the type 2 cytokines, IL-9 and IL-13, as well as the transcription factor, PPAR-γ. However, the functional role of PPAR-γ in human TH9 cells remains unknown. Here, we demonstrate that PPAR-γ drives activation-induced glycolysis, which, in turn, promotes the expression of IL-9, but not IL-13, in an mTORC1-dependent manner. In vitro and ex vivo experiments show that the PPAR-γ-mTORC1-IL-9 pathway is active in TH9 cells in human skin inflammation. Additionally, we find dynamic regulation of tissue glucose levels in acute allergic skin inflammation, suggesting that in situ glucose availability is linked to distinct immunological functions in vivo. Furthermore, paracrine IL-9 induces expression of the lactate transporter, MCT1, in TH cells and promotes their aerobic glycolysis and proliferative capacity. Altogether, our findings uncover a hitherto unknown relationship between PPAR-γ-dependent glucose metabolism and pathogenic effector functions in human TH9 cells.

28 April 2018 in Rheumatology International
Verified
Journal Article
Closed access
PDF file
MBMichael Benzaquen
Michael Benzaquen
BFBenoit Flachaire
Benoit Flachaire
FRFranck Rouby
Franck Rouby
PBPhilippe Berbis
Philippe Berbis
SGSandrine Guis
Sandrine Guis

18 June 2015 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MBMichael Benzaquen
Michael Benzaquen
DBD. Brajon
D. Brajon
MDM. Delord
M. Delord
NYNicolas Yin
Nicolas Yin
FBFadi Bittar
Fadi Bittar
Philippe ParolaPhilippe Parola
Philippe Parola

30 March 2021 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
CJC. Juzot
C. Juzot
VSV. Sibaud
V. Sibaud
FAF. Amatore
F. Amatore
SMS. Mansard
S. Mansard
VSV. Seta
V. Seta
GQG. Quéreux
G. Quéreux